NCT03815643 2025-12-04Avelumab Program Rollover StudyEMD SeronoPhase 3 Active not recruiting205 enrolled
NCT05059522 2025-06-25Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are ClosingPfizerPhase 3 Active not recruiting68 enrolled